Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment

Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy

(2012) Peter Bobbert et al.   BLOOD COAGULATION & FIBRINOLYSIS

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

(2012) Giorgia De Berardis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Case-Population Study Design

(2011) Hélène Théophile et al.   DRUG SAFETY

High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel

(2011) Pavel Osmancik et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Gender Differences in Utilization of Preventive Care Services in the United States

(2011) Varun Vaidya et al.   JOURNAL OF WOMENS HEALTH

Major bleeding risk associated with warfarin and co-medications in the elderly population

(2011) Agnes I. Vitry et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands

(2010) Eline M. Rodenburg et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States

(2010) R. M. Pinkhasov et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The Relative Efficacy and Safety of Clopidogrel in Women and Men

(2009) Jeffrey S. Berger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene

(2008) Peter Staritz et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY